Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-04-07 @ 12:42 PM
Study NCT ID:
NCT07383818
Status:
RECRUITING
Last Update Posted:
2026-02-03
First Post:
2026-01-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTORCH-BREAST 08)
Sponsor:
First Affiliated Hospital of Zhejiang University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-02-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-02-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2031-02-01
Completion Date Type:
ESTIMATED
First Submit Date:
2026-01-26
First Submit QC Date:
None
Study First Post Date:
2026-02-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-01-26
Last Update Post Date:
2026-02-03
Last Update Post Date Type:
ACTUAL